Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...
-
Working with Parent Project Muscular Dystrophy and the Duchenne Registry on patient identification and trial awareness efforts ~15,000 children are living with DMD in the U.S. NEW YORK, April 10,...
-
ORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 25th Annual Needham Virtual Healthcare Conference. Iradimed’s...
-
Paris, France, April 10, 2026 (GLOBE NEWSWIRE) -- Matricis.ai, a healthcare technology company developing artificial intelligence solutions for gynecological imaging in a global women’s imaging...
-
Provo, UT, April 10, 2026 (GLOBE NEWSWIRE) -- Novarad will exhibit at the Society of Interventional Radiology (SIR) Annual Scientific Meeting, taking place April 11–15, 2026, in Toronto, Canada....
-
New York, NY, April 10, 2026 (GLOBE NEWSWIRE) -- After an award-winning film festival season, including 2 Emmy Awards, 3 Webby Awards, 5 Telly Awards, and an NAACP Image Award for Outstanding Short...
-
TORONTO, April 10, 2026 (GLOBE NEWSWIRE) -- Humber River Health has announced that its Wilson site will be renamed Hennick Humber Hospital in recognition of a transformational $50 million gift from...
-
Chicago, IL, April 10, 2026 (GLOBE NEWSWIRE) -- Cook County Health’s Medicaid Impact Workgroup today announced the launch of Get Medicaid Facts, a microsite and communications toolkit designed to...
-
NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- via AINewsWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by AINewsWire ("AINW"), one of 75+...
-
HOUSTON, April 10, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with...